Literature DB >> 7729921

A recombinant Leishmania chagasi antigen that stimulates cellular immune responses in infected mice.

M E Wilson1, B M Young, K P Andersen, J V Weinstock, A Metwali, K M Ali, J E Donelson.   

Abstract

Cellular immune mechanisms resulting in gamma interferon production are critical for protection against visceral leishmaniasis. Antigens stimulating T-cell responses are likely present in the intracellular amastigote form of the parasite, since this is the form found in a mammalian host. To identify T-cell antigens of Leishmania chagasi, the parasite causing South American visceral leishmaniasis, we used a double antibody-T-cell technique to screen an amastigote cDNA library. One cDNA selected (Lcr1) encodes an antigen that stimulated proliferation of splenic T lymphocytes from infected mice that were either resistant (C3H.HeJ) or susceptible (BALB/c) to L. chagasi infection. The Lcr1 cDNA contains four highly divergent 201-bp repeats homologous to the 204-bp repeat of a Trypanosoma cruzi flagellar antigen gene. Results are consistent with a single copy of the Lcr1 gene producing an mRNA of > 10 kb and a protein of > 200 kDa. Recombinant Lcr1, cloned adjacent to polyhistidine and purified on a nickel affinity column, stimulated gamma interferon but not interleukin-4 (IL-4), IL-5, or IL-10 secretion by T-cell-enriched splenocytes from either susceptible or resistant mice during L. chagasi infection. Immunization with Lcr1 partially protected BALB/c mice against challenge with L. chagasi, indicating the utility of the double screening approach in selecting relevant T-cell antigens.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7729921      PMCID: PMC173265          DOI: 10.1128/iai.63.5.2062-2069.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  50 in total

1.  Murine Th1 and Th2 clones proliferate optimally in response to distinct antigen-presenting cell populations.

Authors:  T F Gajewski; M Pinnas; T Wong; F W Fitch
Journal:  J Immunol       Date:  1991-03-15       Impact factor: 5.422

2.  Diminished in vitro production of interleukin-1 and tumor necrosis factor-alpha during acute visceral leishmaniasis and recovery after therapy.

Authors:  J L Ho; R Badaró; A Schwartz; C A Dinarello; J A Gelfand; J Sobel; A Barral; M B Netto; E M Carvalho; S G Reed
Journal:  J Infect Dis       Date:  1992-06       Impact factor: 5.226

3.  Dynamic analysis of splenic Th1 and Th2 lymphocyte functions in mice infected with Schistosoma japonicum.

Authors:  Y H Xu; J Macedonia; A Sher; E Pearce; A W Cheever
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

4.  Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis.

Authors:  F P Heinzel; M D Sadick; S S Mutha; R M Locksley
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

5.  Differential production of Th1- and Th2-derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis.

Authors:  P M Kaye; A J Curry; J M Blackwell
Journal:  J Immunol       Date:  1991-04-15       Impact factor: 5.422

6.  Stimulation of human T lymphocytes by Leishmania lipophosphoglycan-associated proteins.

Authors:  D M Russo; S J Turco; J M Burns; S G Reed
Journal:  J Immunol       Date:  1992-01-01       Impact factor: 5.422

7.  IL-10 inhibits cytokine production by activated macrophages.

Authors:  D F Fiorentino; A Zlotnik; T R Mosmann; M Howard; A O'Garra
Journal:  J Immunol       Date:  1991-12-01       Impact factor: 5.422

8.  Characterization of a membrane antigen of Leishmania amazonensis that stimulates human immune responses.

Authors:  J M Burns; J M Scott; E M Carvalho; D M Russo; C J March; K P Van Ness; S G Reed
Journal:  J Immunol       Date:  1991-01-15       Impact factor: 5.422

Review 9.  Experimental leishmaniasis in humans: review.

Authors:  P C Melby
Journal:  Rev Infect Dis       Date:  1991 Sep-Oct

10.  IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis.

Authors:  P Scott
Journal:  J Immunol       Date:  1991-11-01       Impact factor: 5.422

View more
  19 in total

1.  Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis.

Authors:  P C Melby; J Yang; W Zhao; L E Perez; J Cheng
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

2.  A novel Leishmania infantum recombinant antigen which elicits interleukin 10 production by peripheral blood mononuclear cells of patients with visceral leishmaniasis.

Authors:  I Suffia; B Ferrua; X Stien; B Mograbi; P Marty; D Rousseau; K Fragaki; J Kubar
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

3.  Leishmania infantum sterol 24-c-methyltransferase formulated with MPL-SE induces cross-protection against L. major infection.

Authors:  Yasuyuki Goto; Ajay Bhatia; Vanitha S Raman; Silvia E Z Vidal; Sylvie Bertholet; Rhea N Coler; Randall F Howard; Steven G Reed
Journal:  Vaccine       Date:  2009-03-09       Impact factor: 3.641

4.  Protective immunization against visceral leishmaniasis using Leishmania sterol 24-c-methyltransferase formulated in adjuvant.

Authors:  Yasuyuki Goto; Lisa Y Bogatzki; Sylvie Bertholet; Rhea N Coler; Steven G Reed
Journal:  Vaccine       Date:  2007-08-20       Impact factor: 3.641

5.  Immune responses of Iranian patients with visceral leishmaniasis and recovered individuals to LCR1 of Leishmania infantum.

Authors:  Hamid M Niknam; Firoozeh Abrishami; Mohammad Doroudian; Mosayeb Rostamian; Maryam Moradi; Vahid Khaze; Davood Iravani
Journal:  Clin Vaccine Immunol       Date:  2014-02-05

6.  Characterization of Leishmania donovani antigens encapsulated in liposomes that induce protective immunity in BALB/c mice.

Authors:  Farhat Afrin; Ravindran Rajesh; Khairul Anam; Meenakshisundram Gopinath; Swati Pal; Nahid Ali
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

7.  Characterization of an antigen from Leishmania amazonensis amastigotes able to elicit protective responses in a murine model.

Authors:  C G Beyrodt; A R Pinto; E Freymüller; C L Barbiéri
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

8.  Adjuvanticity and protective immunity elicited by Leishmania donovani antigens encapsulated in positively charged liposomes.

Authors:  F Afrin; N Ali
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

9.  Structure and dynamics studies of sterol 24-C-methyltransferase with mechanism based inactivators for the disruption of ergosterol biosynthesis.

Authors:  Syed Sikander Azam; Asma Abro; Saad Raza; Ayman Saroosh
Journal:  Mol Biol Rep       Date:  2014-02-27       Impact factor: 2.316

10.  Biochemical analysis and immunogenicity of Leishmania major amastigote fractions in cutaneous leishmaniasis.

Authors:  S Rafati; S Couty-Jouve; M H Alimohammadian; J A Louis
Journal:  Clin Exp Immunol       Date:  1997-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.